ヒト免疫不全ウイルス(HIV)迅速検査キットの世界市場2024~2028

■ 英語タイトル:Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2024-2028

調査会社Technavio社が発行したリサーチレポート(データ管理コード:IRTNTR45322-23)■ 発行会社/調査会社:Technavio
■ 商品コード:IRTNTR45322-23
■ 発行日:2023年10月25日
■ 調査対象地域:北米、ヨーロッパ、アジア、その他地域
■ 産業分野:医療
■ ページ数:約120
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[ヒト免疫不全ウイルス(HIV)迅速検査キットの世界市場2024~2028]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

ヒト免疫不全ウイルス(HIV)迅速検査キット市場 2024〜2028年ヒト免疫不全ウイルス(HIV)迅速検査キット市場は、2023年から2028年にかけて2億9496万米ドルの成長が予測され、予測期間中のCAGRは6.52%で加速すると予測されています。この調査レポートは、ヒト免疫不全ウイルス(HIV)迅速検査キット市場の全体的な分析、市場規模、予測、動向、成長促進要因、課題を掲載し、約25のベンダーを網羅したベンダー分析も掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供します。HIV検査に対する啓発プログラムの増加、HIVのポイントオブケア検査に対する需要の高まり、HIVの高い有病率などが市場を牽引しています。

Technavioのヒト免疫不全ウイルス(HIV)迅速検査キット市場は以下のように区分されます。
エンドユーザー別
- 診断センター
- 病院
- 診療所

タイプ別
- HIV迅速免疫測定検査
- HIV迅速分子診断検査

地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、今後数年間のヒト免疫不全ウイルス(HIV)迅速検査キット市場の成長を促進する主な理由の1つとして、HIVの婚前スクリーニングを増加させる取り組みを挙げています。また、研究者による臨床研究の増加やメーカーによるプロモーション活動、ベンダーによる幅広いHIV迅速検査キットの提供は、市場の大きな需要につながるでしょう。

この調査レポートは、ヒト免疫不全ウイルス(HIV)迅速検査キット市場を調査・分析した市場調査報告書です。
- ヒト免疫不全ウイルス(HIV)迅速検査キット市場規模
- ヒト免疫不全ウイルス(HIV)迅速検査キット市場予測
- ヒト免疫不全ウイルス(HIV)迅速検査キット市場産業分析

本レポートでは、ヒト免疫不全ウイルス(HIV)迅速検査キット市場の主要ベンダーとして、Abbott Laboratories、AccuQuik Test Kits、Amkay Products Pvt、 Becton Dickinson and Co.、Bhat Bio Tech India Pvt Ltd.、bioLytical Laboratories Inc.、bioMerieux SA、Chembio Diagnostics Inc.、Danaher Corp.、DrSafeHands、F. Hoffmann La Roche Ltd.、Fujirebio Holdings Inc.、Healgen Scientific, LLC、Hologic Inc.、J. Mitra and Co. Ltd.、MP Biomedicals Inc.、Oragenics Inc.、OraSure Technologies Inc.、Pathkits Heathcare Pvt.Ltd.、SHINE SAなどを分析しています。また、ヒト免疫不全ウイルス(HIV)迅速検査キット市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。
当調査会社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1 エグゼクティブサマリー
2 市場状況
3 市場規模
4 過去の市場規模
5 ファイブフォース分析
6 ヒト免疫不全ウイルス(HIV)迅速検査キットの世界市場:エンドユーザー別市場分析
7 ヒト免疫不全ウイルス(HIV)迅速検査キットの世界市場:タイプ別市場分析
8 顧客状況
9 地域別状況
10 推進要因・課題・動向
11 企業状況
12 企業分析
13 付録

世界の市場調査レポート販売サイト(H&Iグローバルリサーチ株式会社運営)
*** レポート目次(コンテンツ)***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global human immunodeficiency virus (HIV) rapid test kits market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global human immunodeficiency virus (hiv) rapid test kits market 2018 – 2022 ($ million)
o 4.2 End-user Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – End-user Segment 2018 – 2022 ($ million)
o 4.3 Type Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Type Segment 2018 – 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user – Market share 2023-2028 (%)
o Exhibit 31: Data Table on End-user – Market share 2023-2028 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Diagnostic centers – Market size and forecast 2023-2028
o Exhibit 34: Chart on Diagnostic centers – Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Diagnostic centers – Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Diagnostic centers – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Diagnostic centers – Year-over-year growth 2023-2028 (%)
o 6.4 Hospitals and clinics – Market size and forecast 2023-2028
o Exhibit 38: Chart on Hospitals and clinics – Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Hospitals and clinics – Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Hospitals and clinics – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Hospitals and clinics – Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by End-user
o Exhibit 42: Market opportunity by End-user ($ million)
o Exhibit 43: Data Table on Market opportunity by End-user ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 44: Chart on Type – Market share 2023-2028 (%)
o Exhibit 45: Data Table on Type – Market share 2023-2028 (%)
o 7.2 Comparison by Type
o Exhibit 46: Chart on Comparison by Type
o Exhibit 47: Data Table on Comparison by Type
o 7.3 HIV rapid immunoassay test – Market size and forecast 2023-2028
o Exhibit 48: Chart on HIV rapid immunoassay test – Market size and forecast 2023-2028 ($ million)
o Exhibit 49: Data Table on HIV rapid immunoassay test – Market size and forecast 2023-2028 ($ million)
o Exhibit 50: Chart on HIV rapid immunoassay test – Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on HIV rapid immunoassay test – Year-over-year growth 2023-2028 (%)
o 7.4 HIV rapid molecular diagnostic test – Market size and forecast 2023-2028
o Exhibit 52: Chart on HIV rapid molecular diagnostic test – Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on HIV rapid molecular diagnostic test – Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on HIV rapid molecular diagnostic test – Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on HIV rapid molecular diagnostic test – Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Type
o Exhibit 56: Market opportunity by Type ($ million)
o Exhibit 57: Data Table on Market opportunity by Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share by geography 2023-2028 (%)
o Exhibit 60: Data Table on Market share by geography 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 63: Chart on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 64: Data Table on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 65: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 66: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 67: Chart on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 68: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 69: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 71: Chart on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 75: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 79: Chart on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 UK – Market size and forecast 2023-2028
o Exhibit 83: Chart on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on UK – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on UK – Year-over-year growth 2023-2028 (%)
o 9.9 China – Market size and forecast 2023-2028
o Exhibit 87: Chart on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on China – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on China – Year-over-year growth 2023-2028 (%)
o 9.10 Germany – Market size and forecast 2023-2028
o Exhibit 91: Chart on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.11 Canada – Market size and forecast 2023-2028
o Exhibit 95: Chart on Canada – Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on Canada – Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on Canada – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Canada – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity by geography
o Exhibit 99: Market opportunity by geography ($ million)
o Exhibit 100: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 107: Abbott Laboratories – Overview
o Exhibit 108: Abbott Laboratories – Business segments
o Exhibit 109: Abbott Laboratories – Key news
o Exhibit 110: Abbott Laboratories – Key offerings
o Exhibit 111: Abbott Laboratories – Segment focus
o 12.4 AccuQuik Test Kits
o Exhibit 112: AccuQuik Test Kits – Overview
o Exhibit 113: AccuQuik Test Kits – Product / Service
o Exhibit 114: AccuQuik Test Kits – Key offerings
o 12.5 Becton Dickinson and Co.
o Exhibit 115: Becton Dickinson and Co. – Overview
o Exhibit 116: Becton Dickinson and Co. – Business segments
o Exhibit 117: Becton Dickinson and Co. – Key news
o Exhibit 118: Becton Dickinson and Co. – Key offerings
o Exhibit 119: Becton Dickinson and Co. – Segment focus
o 12.6 bioLytical Laboratories Inc.
o Exhibit 120: bioLytical Laboratories Inc. – Overview
o Exhibit 121: bioLytical Laboratories Inc. – Product / Service
o Exhibit 122: bioLytical Laboratories Inc. – Key offerings
o 12.7 bioMerieux SA
o Exhibit 123: bioMerieux SA – Overview
o Exhibit 124: bioMerieux SA – Product / Service
o Exhibit 125: bioMerieux SA – Key news
o Exhibit 126: bioMerieux SA – Key offerings
o 12.8 Chembio Diagnostics Inc.
o Exhibit 127: Chembio Diagnostics Inc. – Overview
o Exhibit 128: Chembio Diagnostics Inc. – Product / Service
o Exhibit 129: Chembio Diagnostics Inc. – Key offerings
o 12.9 Danaher Corp.
o Exhibit 130: Danaher Corp. – Overview
o Exhibit 131: Danaher Corp. – Business segments
o Exhibit 132: Danaher Corp. – Key news
o Exhibit 133: Danaher Corp. – Key offerings
o Exhibit 134: Danaher Corp. – Segment focus
o 12.10 DrSafeHands
o Exhibit 135: DrSafeHands – Overview
o Exhibit 136: DrSafeHands – Product / Service
o Exhibit 137: DrSafeHands – Key offerings
o 12.11 F. Hoffmann La Roche Ltd.
o Exhibit 138: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 139: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 140: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 141: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 142: F. Hoffmann La Roche Ltd. – Segment focus
o 12.12 Fujirebio Holdings Inc.
o Exhibit 143: Fujirebio Holdings Inc. – Overview
o Exhibit 144: Fujirebio Holdings Inc. – Product / Service
o Exhibit 145: Fujirebio Holdings Inc. – Key offerings
o 12.13 Healgen Scientific, LLC
o Exhibit 146: Healgen Scientific, LLC – Overview
o Exhibit 147: Healgen Scientific, LLC – Product / Service
o Exhibit 148: Healgen Scientific, LLC – Key offerings
o 12.14 Hologic Inc.
o Exhibit 149: Hologic Inc. – Overview
o Exhibit 150: Hologic Inc. – Business segments
o Exhibit 151: Hologic Inc. – Key news
o Exhibit 152: Hologic Inc. – Key offerings
o Exhibit 153: Hologic Inc. – Segment focus
o 12.15 J. Mitra and Co. Pvt. Ltd.
o Exhibit 154: J. Mitra and Co. Pvt. Ltd. – Overview
o Exhibit 155: J. Mitra and Co. Pvt. Ltd. – Product / Service
o Exhibit 156: J. Mitra and Co. Pvt. Ltd. – Key offerings
o 12.16 MP Biomedicals Inc.
o Exhibit 157: MP Biomedicals Inc. – Overview
o Exhibit 158: MP Biomedicals Inc. – Key offerings
o 12.17 OraSure Technologies Inc.
o Exhibit 159: OraSure Technologies Inc. – Overview
o Exhibit 160: OraSure Technologies Inc. – Business segments
o Exhibit 161: OraSure Technologies Inc. – Key offerings
o Exhibit 162: OraSure Technologies Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 163: Inclusions checklist
o Exhibit 164: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 165: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 166: Research methodology
o Exhibit 167: Validation techniques employed for market sizing
o Exhibit 168: Information sources
o 13.5 List of abbreviations
o Exhibit 169: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by End-user
Exhibits6: Executive Summary – Chart on Market Segmentation by Type
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global human immunodeficiency virus (hiv) rapid test kits market 2018 – 2022 ($ million)
Exhibits19: Historic Market Size – End-user Segment 2018 – 2022 ($ million)
Exhibits20: Historic Market Size – Type Segment 2018 – 2022 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on End-user – Market share 2023-2028 (%)
Exhibits31: Data Table on End-user – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Diagnostic centers – Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Diagnostic centers – Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Diagnostic centers – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Diagnostic centers – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Hospitals and clinics – Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Hospitals and clinics – Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Hospitals and clinics – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Hospitals and clinics – Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by End-user ($ million)
Exhibits43: Data Table on Market opportunity by End-user ($ million)
Exhibits44: Chart on Type – Market share 2023-2028 (%)
Exhibits45: Data Table on Type – Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Type
Exhibits47: Data Table on Comparison by Type
Exhibits48: Chart on HIV rapid immunoassay test – Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on HIV rapid immunoassay test – Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on HIV rapid immunoassay test – Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on HIV rapid immunoassay test – Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on HIV rapid molecular diagnostic test – Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on HIV rapid molecular diagnostic test – Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on HIV rapid molecular diagnostic test – Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on HIV rapid molecular diagnostic test – Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Type ($ million)
Exhibits57: Data Table on Market opportunity by Type ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share by geography 2023-2028 (%)
Exhibits60: Data Table on Market share by geography 2023-2028 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America – Market size and forecast 2023-2028 ($ million)
Exhibits64: Data Table on North America – Market size and forecast 2023-2028 ($ million)
Exhibits65: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits67: Chart on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on US – Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on US – Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on UK – Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on UK – Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on UK – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on UK – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on China – Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on China – Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on China – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on China – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Canada – Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Canada – Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Canada – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Canada – Year-over-year growth 2023-2028 (%)
Exhibits99: Market opportunity by geography ($ million)
Exhibits100: Data Tables on Market opportunity by geography ($ million)
Exhibits101: Impact of drivers and challenges in 2023 and 2028
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Abbott Laboratories – Overview
Exhibits108: Abbott Laboratories – Business segments
Exhibits109: Abbott Laboratories – Key news
Exhibits110: Abbott Laboratories – Key offerings
Exhibits111: Abbott Laboratories – Segment focus
Exhibits112: AccuQuik Test Kits – Overview
Exhibits113: AccuQuik Test Kits – Product / Service
Exhibits114: AccuQuik Test Kits – Key offerings
Exhibits115: Becton Dickinson and Co. – Overview
Exhibits116: Becton Dickinson and Co. – Business segments
Exhibits117: Becton Dickinson and Co. – Key news
Exhibits118: Becton Dickinson and Co. – Key offerings
Exhibits119: Becton Dickinson and Co. – Segment focus
Exhibits120: bioLytical Laboratories Inc. – Overview
Exhibits121: bioLytical Laboratories Inc. – Product / Service
Exhibits122: bioLytical Laboratories Inc. – Key offerings
Exhibits123: bioMerieux SA – Overview
Exhibits124: bioMerieux SA – Product / Service
Exhibits125: bioMerieux SA – Key news
Exhibits126: bioMerieux SA – Key offerings
Exhibits127: Chembio Diagnostics Inc. – Overview
Exhibits128: Chembio Diagnostics Inc. – Product / Service
Exhibits129: Chembio Diagnostics Inc. – Key offerings
Exhibits130: Danaher Corp. – Overview
Exhibits131: Danaher Corp. – Business segments
Exhibits132: Danaher Corp. – Key news
Exhibits133: Danaher Corp. – Key offerings
Exhibits134: Danaher Corp. – Segment focus
Exhibits135: DrSafeHands – Overview
Exhibits136: DrSafeHands – Product / Service
Exhibits137: DrSafeHands – Key offerings
Exhibits138: F. Hoffmann La Roche Ltd. – Overview
Exhibits139: F. Hoffmann La Roche Ltd. – Business segments
Exhibits140: F. Hoffmann La Roche Ltd. – Key news
Exhibits141: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits142: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits143: Fujirebio Holdings Inc. – Overview
Exhibits144: Fujirebio Holdings Inc. – Product / Service
Exhibits145: Fujirebio Holdings Inc. – Key offerings
Exhibits146: Healgen Scientific, LLC – Overview
Exhibits147: Healgen Scientific, LLC – Product / Service
Exhibits148: Healgen Scientific, LLC – Key offerings
Exhibits149: Hologic Inc. – Overview
Exhibits150: Hologic Inc. – Business segments
Exhibits151: Hologic Inc. – Key news
Exhibits152: Hologic Inc. – Key offerings
Exhibits153: Hologic Inc. – Segment focus
Exhibits154: J. Mitra and Co. Pvt. Ltd. – Overview
Exhibits155: J. Mitra and Co. Pvt. Ltd. – Product / Service
Exhibits156: J. Mitra and Co. Pvt. Ltd. – Key offerings
Exhibits157: MP Biomedicals Inc. – Overview
Exhibits158: MP Biomedicals Inc. – Key offerings
Exhibits159: OraSure Technologies Inc. – Overview
Exhibits160: OraSure Technologies Inc. – Business segments
Exhibits161: OraSure Technologies Inc. – Key offerings
Exhibits162: OraSure Technologies Inc. – Segment focus
Exhibits163: Inclusions checklist
Exhibits164: Exclusions checklist
Exhibits165: Currency conversion rates for US$
Exhibits166: Research methodology
Exhibits167: Validation techniques employed for market sizing
Exhibits168: Information sources
Exhibits169: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IRTNTR45322-23 )"ヒト免疫不全ウイルス(HIV)迅速検査キットの世界市場2024~2028" (英文:Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2024-2028)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。